HOME >> BIOLOGY >> NEWS
Almac Diagnostics announces pioneering genetic research on ductal carcinoma in situ

CRAIGAVON, NORTHERN IRELAND, 8 Aug 2007 Today Almac Diagnostics announced a major study analysing ductal carcinoma in situ tissue samples using its novel Breast Cancer DSA microarray. DSA research tools focus on the transcriptome of an individual disease, in this case breast cancer, and contain significant additional data, relevant to the disease of interest that is not available on other generic microarrays. The study will be conducted in collaboration with Prof Adrian Harris, Cancer Research UK and Professor of Medical Oncology at the University of Oxford.

Our novel technology is helping researchers to reduce discovery timelines, accelerate the validation process and ultimately deliver clinical applications in this disease setting. said Paul Harkin, BSc, PhD, Professor of Molecular Oncology at the Centre for Cancer Research and Cell Biology, Queens University, Belfast and MD and President of Almac Diagnostics.

This particular study aims to generate a gene signature to identify the subset of DCIS patients who are likely to suffer a recurrence, he added.

The study will use paraffin embedded samples and is due to commence in the coming weeks. Tissue samples will be analysed using the Breast Cancer DSA research tool. An Almac bioinformatics team will interrogate the resulting data to identify any potential signature.

Our research will use the Breast Cancer DSA microarray to examine the transcriptome of ductal carcinoma in situ at a greater level of specificity generating additional information that will help us draw meaningful conclusions from our data. Eventually we hope to develop a gene expression signature that will inform clinical treatment strategies" said Prof Adrian Harris, Cancer Research UK Professor of Medical Oncology at the University of Oxford and Principal Investigator on the study.

In some cases, the treatment for DCIS is total mastectomy as it is curative in nearly all patients1. However, t
'"/>

Contact: Vanessa Leon
vanessa.leon@edelman.com
44-207-344-1344
Edelman Public Relations
8-Aug-2007


Page: 1 2

Related biology news :

1. Almac Diagnostics attends pre-IDE meeting with FDA
2. Almac Diagnostics announces pioneering genetic research on colorectal pre-malignancies
3. ESA announces 2007 award recipients
4. President Bush announces 2005 and 2006 Laureates of National Medals of Science and Technology
5. Conservation Leadership Program announces 2007 awardees
6. ACMG Foundation announces 2007-2008 Luminex/ACMGF award recipient
7. Revolutionary global environment fund announces $50M expansion
8. Biovest announces interim blinded data of fast-tracked pivotal Phase 3 clinical trial of BiovaxID
9. Cell Press announces new partnership with the American Society of Human Genetics
10. ChemGenex announces publication confirming activity of Ceflatonin in T315I-Positive CML
11. Minister Lunn announces $39.6M for next phase of mountain pine beetle response

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:7/9/2019)... ... July 08, 2019 , ... ... of Danisco’s ownership of the innovation behind two Danisco amylase patent applications (EP2859097 ... could be based on prior art was without merit and awarded costs to ...
(Date:6/24/2019)... ... 24, 2019 , ... According to the World Health Organization , over ... STDs: chlamydia, gonorrhea, trichomoniasis (or "trich") and syphilis. And that’s not counting HIV. ... men accounted for the largest number of HIV diagnoses (9,807), followed by Hispanic/Latino men ...
(Date:6/16/2019)... (PRWEB) , ... June 14, 2019 , ... ... Americans invited to lecture at the fifth annual Neodent World Congress. Attended by ... the innovative progress and latest advancements in the world of dentistry. The three-day ...
Breaking Biology News(10 mins):
(Date:7/11/2019)... ... ... At the most recent stem cell training course in Las Vegas ... Heroes Program. The Veterans included individuals and families from all over the US, with ... military Veteran, teacher or first responder to receive a regenerative therapy at a training ...
(Date:6/18/2019)... ... June 17, 2019 , ... ... entered into an agreement for production and manufacturing of GMP-grade adeno-associated virus (AAV) ... rhodopsin-mediated autosomal dominant retinitis pigmentosa (RHO-adRP) and IC-200 for the treatment of BEST1 ...
(Date:6/11/2019)... CITY, Calif. (PRWEB) , ... June 10, 2019 ... ... (IOPP) today announced IOPP will add 80 of its scientific journals to DeepDyve’s ... of physics-related content to DeepDyve’s continually expanding library of more than 20 million ...
(Date:5/31/2019)... TORONTO (PRWEB) , ... May 29, 2019 , ... For ... but the toughest forms of cancer demand breakthrough therapies. Advances in immuno-oncology have led ... a patient’s own T cells with engineered T cell receptors known as “CARs”. The ...
Breaking Biology Technology:
Cached News: